The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.

Oneok upgraded at Wolfe Research, saying the stock has fallen out of favor on near-term Bakken headwinds and its valuation has quickly shifted to a big discount to large-cap peers.

Wolfe Research reaffirmed its Outperform rating and $108.00 price target for Okta, Inc (NASDAQ:OKTA), coinciding with Okta's announcement of leadership changes. The cybersecurity company, currently ...

Wolfe Research reiterated its Outperform rating on Charles Schwab Corporation (NYSE:SCHW), a $148 billion financial services giant with an impressive 96.99% gross profit margin, maintaining a steady ...